mast cell research
Enhance your drug development
Unlock the potential of mast cell research with Genoskin’s In Vitro human mast cell services for drug development.
Mast cells play a critical role in allergic and inflammatory responses, yet evaluating their activation and degranulation remains challenging with conventional cell lines that may not fully reflect human mast cell biology.
Genoskin’s primary human mast cell platform provides mature, functional, connective tissue-type mast cells (CTMCs) derived from human blood progenitors. These cells closely resemble human skin mast cells and support research into drug-induced hypersensitivity, immune modulation, mast cell activation and inhibition, and drug safety and efficacy.
The fact sheet presents the key features, research applications, and biological validation data, including receptor expression (CD117, FcεRI, MRGPRX2), β-hexosaminidase release, and CD63-based degranulation analysis.
Download the fact sheet to explore how primary human mast cells can support your drug discovery and safety assessment studies.
To learn more about our mast cell services and how they can enhance your drug development, please fill in the form below to access our fact sheet.
After submitting this form, you will receive an email containing the link to access our poster.
Comments are closed.